MacroGenics
MGNX
#9010
Rank
โ‚น11.27 B
Marketcap
โ‚น178.28
Share price
-2.51%
Change (1 day)
-10.60%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.59. In 2024 the company made an earnings per share (EPS) of -โ‚น98.33 a decrease over its 2023 EPS that were of -โ‚น13.78.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.94%
2024-โ‚น98.33613.33%
2023-โ‚น13.78-92.31%
2022-โ‚น179.20-42.14%
2021-โ‚น309.6936.44%
2020-โ‚น226.99-21.84%
2019-โ‚น290.39-24.58%
2018-โ‚น385.05675.93%
2017-โ‚น49.62-68.05%
2016-โ‚น155.31168.25%
2015-โ‚น57.90-55%
2014-โ‚น128.663400%
2013-โ‚น3.68-108.68%
2012โ‚น42.3624.49%
2011โ‚น34.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.98-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,115-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,317-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น599.17-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น671.47-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น272.93-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น162.66 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA